Bull has experience of hundreds of large VPN and secure Internet gateway projects for the most sensitive organizations.
NSIA uses its infrastructure to support its strategy
Pioneering African bank-assurer NSIA turns to Bull to support its growth strategy. The need to constantly optimize its infrastructures means the group has opted for a virtualized infrastructure and put in place a comprehensive business continuity/disaster recovery plan. And it turned to Bull to deliver the totally integrated solution, consisting of three Bull NovaScale™ (R480 F2) servers, Microsoft Hyper V and EMC for storage.
Belgian healthcare group calls on Bull to a value-added hospital IT solution
The Entité Jolimontoise turned to Bull to implement a Single Sign-On (SSO) for IT users. The first phase of the project is currently under way. A second stage will involve introducing strong authentication, using a physical identification method such as a Digipass or smart card, which will really allow, medical and nursing staff and paramedics to access a central information platform about the patient from literally anywhere, in total security. These vital projects are building the foundations for more open and scalable IT systems, that will be capable of taking full advantage of the benefits of Cloud computing in the coming years, for example.
The European Union adopts globull™
The General Secretariat of the Council of the European Union (GSC EU) has acquired globull devices – the encryption-protected mobile office designed and developed by Bull – with the aim of equipping its diplomatic staff. The GSC EU’s 3,500 officers often need to travel and take with them highly confidential documents. For a number of years now, as part of its NOMAD project, the GSC EU has been looking for a reliable, easy-to-use solution that combines security and mobility. globull, with its defense-standard technologies, carefully-designed ergonomics and smart look & feel, has won over the INFOSEC experts at the General Secretariat. After rigorous testing, configuration and trialing program, globull was officially presented to the 27 member States of the EU.